Summary
The induction of 2-break chromosome aberrations (dicentrics and ring chromosomes) in human lymphocytes by the antitumor agents bleomycin and peplomycin is strongly enhanced when those agents are applied together with the heart drug verapamil (isoptin).
References
Hossfeld, D.K., ed., Wirkung und Nebenwirkungen von Bleomycin. Contr. Oncology vol. 12. Karger, Basel 1982.
Carter, S.K., Crooke, S.T., and Umezawa, H., eds, Bleomycin. Current status and new developments. Academic Press, New York 1978.
Hecht, S.M., ed., Bleomycin: chemical, biochemical, and biological aspects. Springer, New York/Heidelberg/Berlin 1979.
Mizuno, S., and Ishida, A., Biochem. biophys. Res. Commun.107 (1982) 1021.
Hittelman, W.N., Sognier, M.A., and Cole, A., in: Radiation biology in cancer research, p. 103. Eds R.E. Meyn and H.R. Withers. Raven Press, New York 1980.
Dresp, J., Schmid, E., and Bauchinger, M., Mut. Res.56 (1978) 341.
Traut, H., and Scheid, W., unpublished results.
Author information
Authors and Affiliations
Additional information
We thank Heinrich Mack Nachf./Illertissen (Germany) for generously supplying both the bleomycin and the peplomycin and Dr P. Engel, Illertissen, for valuable informations.
Rights and permissions
About this article
Cite this article
Scheid, W., Oppelmann, B. & Traut, H. The cytogenetic efficiency of the antitumor agents bleomycin and peplomycin is enhanced by the heart drug verapamil (isoptin). Experientia 40, 746–747 (1984). https://doi.org/10.1007/BF01949756
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01949756